Improving Lives Through

Diagnostic and
Therapeutic Solutions

AXIM’s proprietary research intends to find new ways to diagnose and treat cancer as well as other conditions through laboratory-derived cannabinoid and oncological therapeutics.

Improving Lives Through

Diagnostic and
Therapeutic Solutions

AXIM’s proprietary research intends to find new ways to diagnose and treat cancer as well as other conditions through laboratory-derived cannabinoid and oncological therapeutics.

COVID-19 TESTING

AXIM Biotechnologies has developed the first rapid (10-minute) point-of-care test that measures the concentration of neutralizing antibodies to COVID-19.

CLINICAL therapeutics

AXIM’s clinical therapeutic research focuses around an enzyme called “QSOX1” where the company hopes to bring a novel oncology drug to market 

CANCER dIAGNOSTICS

AXIM is in development of various “point-of-care” diagnostic testing products designed for the early detection of cancer

The Latest On Our Research

AXIM Biotechnologies is a vertically integrated pharmaceutical research company focused on the development of diagnostic tests for the early detection of cancer, research on proprietary small molecules drugs that not only treat cancer but also block metastasis, and research of novel antibodies for therapeutic and diagnostic uses.